Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. Among authors: melia m. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.
Diabetic Retinopathy Clinical Research Network; Elman MJ, Qin H, Aiello LP, Beck RW, Bressler NM, Ferris FL 3rd, Glassman AR, Maturi RK, Melia M. Diabetic Retinopathy Clinical Research Network, et al. Among authors: melia m. Ophthalmology. 2012 Nov;119(11):2312-8. doi: 10.1016/j.ophtha.2012.08.022. Epub 2012 Sep 19. Ophthalmology. 2012. PMID: 22999634 Free PMC article. Clinical Trial.
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG; Diabetic Retinopathy Clinical Research Network. Bressler SB, et al. Among authors: melia m. JAMA Ophthalmol. 2013 Aug;131(8):1033-40. doi: 10.1001/jamaophthalmol.2013.4154. JAMA Ophthalmol. 2013. PMID: 23807371 Free PMC article. Clinical Trial.
Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema.
Diabetic Retinopathy Clinical Research Network Writing Committee; Bressler SB, Edwards AR, Chalam KV, Bressler NM, Glassman AR, Jaffe GJ, Melia M, Saggau DD, Plous OZ. Diabetic Retinopathy Clinical Research Network Writing Committee, et al. Among authors: melia m. JAMA Ophthalmol. 2014 Sep;132(9):1113-22. doi: 10.1001/jamaophthalmol.2014.1698. JAMA Ophthalmol. 2014. PMID: 25058482 Free PMC article.
Randomizing 1 eye or 2 eyes: a missed opportunity.
Glassman AR, Melia M. Glassman AR, et al. Among authors: melia m. JAMA Ophthalmol. 2015 Jan;133(1):9-10. doi: 10.1001/jamaophthalmol.2014.3600. JAMA Ophthalmol. 2015. PMID: 25256889 No abstract available.
Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.
Bressler SB, Almukhtar T, Bhorade A, Bressler NM, Glassman AR, Huang SS, Jampol LM, Kim JE, Melia M; Diabetic Retinopathy Clinical Research Network Investigators. Bressler SB, et al. Among authors: melia m. JAMA Ophthalmol. 2015 May;133(5):589-97. doi: 10.1001/jamaophthalmol.2015.186. JAMA Ophthalmol. 2015. PMID: 25719991 Free PMC article. Clinical Trial.
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
Aiello LP, Ayala AR, Antoszyk AN, Arnold-Bush B, Baker C, Bressler NM, Elman MJ, Glassman AR, Jampol LM, Melia M, Nielsen J, Wolpert HA; Diabetic Retinopathy Clinical Research Network. Aiello LP, et al. Among authors: melia m. JAMA Ophthalmol. 2015 Aug;133(8):888-96. doi: 10.1001/jamaophthalmol.2015.1312. JAMA Ophthalmol. 2015. PMID: 25996273 Free PMC article. Clinical Trial.
Considerations for randomizing 1 eye or 2 eyes--reply.
Glassman AR, Melia M. Glassman AR, et al. Among authors: melia m. JAMA Ophthalmol. 2015 Oct;133(10):1221. doi: 10.1001/jamaophthalmol.2015.2759. JAMA Ophthalmol. 2015. PMID: 26291566 No abstract available.
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Writing Committee for the Diabetic Retinopathy Clinical Research Network; Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, Elman MJ, Ferris FL 3rd, Friedman SM, Marcus DM, Melia M, Stockdale CR, Sun JK, Beck RW. Writing Committee for the Diabetic Retinopathy Clinical Research Network, et al. Among authors: melia m. JAMA. 2015 Nov 24;314(20):2137-2146. doi: 10.1001/jama.2015.15217. JAMA. 2015. PMID: 26565927 Free PMC article. Clinical Trial.
185 results